SCHEMBL19001641

SCHEMBL19001641

Bc1cc(C(C)(C)c2cc(Br)c(OCC=C)c(Br)c2)cc(B)c1OCC=C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
LMNA P02545 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HPGD P15428 3/20 0.37
HSD17B10 Q99714 2/20 0.37
ALOX15 P16050 2/20 0.37
ALOX12 P18054 2/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
CASP1 P29466 1/20 0.37
RECQL P46063 1/20 0.37
HIF1A Q16665 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MEN1 O00255 6/20 0.35
KMT2A Q03164 6/20 0.35
HTT P42858 3/20 0.35
KDM4E B2RXH2 2/20 0.34
PKM P14618 1/20 0.34
CHEK1 O14757 1/20 0.33
DAPK3 O43293 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL827154 0.92 ALDH1A1 (0.53) ALDH1A1LMNASMN1; SMN2HPGDHSD17B10
SCHEMBL12370722 0.86 ALDH1A1 (0.48) ALDH1A1LMNASMN1; SMN2HPGDHSD17B10
SCHEMBL10338842 0.82 LMNA (0.43) ALDH1A1LMNASMN1; SMN2HPGDHSD17B10
SCHEMBL28132523 0.80 ALDH1A1 (0.43) ALDH1A1LMNASMN1; SMN2HSD17B10ALOX15
SCHEMBL17011655 0.80 ALDH1A1 (0.43) ALDH1A1HPGDHSD17B10ALOX15ALOX12
SCHEMBL17011647 0.80 ALDH1A1 (0.43) ALDH1A1HPGDHSD17B10ALOX15ALOX12
SCHEMBL11173586 0.79 ALDH1A1 (0.47) ALDH1A1LMNASMN1; SMN2HPGDHSD17B10
SCHEMBL11174842 0.78 ALDH1A1 (0.46) ALDH1A1LMNASMN1; SMN2HPGDHSD17B10
SCHEMBL12370703 0.76 ALDH1A1 (0.50) ALDH1A1LMNASMN1; SMN2HPGDHSD17B10
SCHEMBL12370698 0.76 HSD17B10 (0.44) ALDH1A1LMNASMN1; SMN2HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307342-B1 DIGLYCIDIC ETHER DERIVATIVE THERAPEUTICS AND METHODS FOR THEIR USE BRITISH COLUMBIA CANCER AGENCY BRANCH (CA) 2017-06-21 EP disclosed